maj 19, 2015
Lund, Sweden, (PRNEWSWIRE) May 13, 2015 - BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery, announced that it has received the Frost & Sullivan 2015 Growth Capital Investment Award for outstanding achievement and superior performance in the area of technological innovation and strategic product development in...
OXFORD, UK - 19 May 2015 - PsiOxus Therapeutics Ltd. (PsiOxus), the oncolytic immuno-oncology company, has closed a Series C financing round of £25 million (c$38.5 million) to progress its lead clinical candidate, enadenotucirev, and a pipeline of follow-on oncolytic programmes from the antibody 'armed' series of AbEnAd viruses.
South San Francisco, CA - May 12, 2015 - Iconic Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to translating an understanding of Tissue Factor biology to new therapeutics for retinal disease and cancer, today announced that K. Peter Hirth, PhD, co-founder and formerly Chief Executive Officer of Plexxikon, Inc., has been named a Director...


90 mio. kr. til 18 talentfulde forskere
19. oktober 2020
Søren Dinesen Lumdbeckfonden
Psykiatriforskning udløser stor videnskabelig pris
13. oktober 2020
Christian Sandøe Musaeus Lundbeckfonden
Han satser på demensområdet
13. oktober 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge